Guardian Pharmacy Services, Inc.
GRDN - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.58B
Close$
$58.03
42.6% upside
Current Fair Value
42.6% upsideUndervalued by 42.6% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.58 Billion |
|---|---|
| Enterprise Value | $2.49 Billion |
| Earnings per Share | $0.79 |
| Beta | 0.1 |
| Outstanding Shares | 63,327,000 |
Return
| Return on Equity | 25.58% |
|---|---|
| Return on Assets | 14.86% |
| Return on Invested Capital | 38.16% |
Valuation & Multiples
| P/E Ratio | 38.75 |
|---|---|
| PEG | 27.25 |
| Price to Sales | 1.77 |
| Price to Book Ratio | 10.17 |
| Enterprise Value to Revenue | 1.7 |
| Enterprise Value to EBIT | 22.57 |
| Enterprise Value to Net Income | 37 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 17, 2026
EPS Estimate
$0.26
Consensus analyst estimateRevenue Estimate
$340.44 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$0.31
Consensus analyst estimateRevenue Estimate
$365.76 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 3.54, the ratio is above 1, so institutions hold more puts than calls. That is a more cautious stance.
| Put/Call Ratio | 3.5392▲ 353.92% |
|---|---|
| Total Calls | 10,200▲ Infinity% |
| Total Puts | 36,100▲ 446.97% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 46.72%▲ 2.00% |
|---|---|
| Total Invested | $1.24B▲ 16.13% |
| Investors Holding | 195▲ 23.00% |
About Guardian Pharmacy Services, Inc.
3,400 employees
CEO: Mr. Fred P. Burke
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug ...